01778nas a2200169 4500000000100000008004100001260005500042653002600097653001600123100001500139700002400154245012100178856026000299300001000559520101400569022002501583 2026 d c05/2026bOvid Technologies (Wolters Kluwer Health)10aPure neuritic leprosy10aCase report1 aSanthosh P1 aKidangazhiathmana A00aComment on the Previously Published Article “Rare Masqueraders of Pure Neuritic Leprosy: A Report of Four Cases” uhttps://scholar.google.nl/scholar_url?url=https://journals.lww.com/idoj/fulltext/9900/comment_on_the_previously_published_article__rare.694.aspx&hl=nl&sa=X&d=13848535091856536854&ei=TWcJaue1F-mq6rQP0vmLiAY&scisig=AFyMTJUdJlsHn7wKn7IqQys0xv6O&oi=scholaralr a1 - 13 a

Dear Editor,

It was with great interest that we read the article titled “Rare Masqueraders of Pure Neuritic Leprosy: A Report of Four Cases” by Sadhukhan et al. The cases described are quite fascinating, and would enlighten the readers on differentials to consider during the evaluation of likely cases of leprosy.

These cases did not have any of the cardinal features of leprosy, of which at least one is essential for a diagnosis of leprosy as per the World Health Organization (WHO): (i) definite loss of sensation in a pale (hypopigmented) or reddish skin patch; (ii) thickened or enlarged peripheral nerve, with loss of sensation and/or weakness of the muscles supplied by that nerve; (iii) microscopic detection of bacilli in a slit-skin smear. Among these, thickened or enlarged peripheral nerves would be the most vital criterion for clinically diagnosing pure neuritic leprosy.

 a2229-5178, 2249-5673